Five Prime Therapeutics Stock Price (NASDAQ:FPRX)

Add to My Stocks
$43.65 $0.15 (0.34%) FPRX stock closing price Jan 23, 2017 (Closing)
YOUR DAILY UPDATE ON
FPRX
Five Prime Therapeutics
23 JAN 2017
amigobulls logo
FPRX hand_up
FPRX vs S&P 500
Closing Price: Jan 23, 2017
FPRX
$43.65 ( 0.34%)
S&P 500
2265.2 ( -0.27%)
FPRX
52 Week Price Range
1 Year Return: 19.7%
Q3 Growth*
Excellent
Profitable ?
Yes
net image
2016 Q3 Net Profit
64.9%
PE Valuation
Cheaper*
home image
Rating
FPRX AVERAGE
☆ ☆ ☆ ☆ ☆★ ★ ★ ★ ★
Double Tap To Exit Full Screen
0:00
/

Five Prime Therapeutics Snapshot Video

11 5 2

FPRX Stock Details

Prev Close* : $43.50
Market Cap:
$1.24B
Day Low: $41.88
52 Week Low: $28.01
Open: $43
Volume: 427692
Day High: $43.82
52 Week High: $60.98
Dividend:
N/A

Latest Stock Market News

Latest Articles

Five Prime Therapeutics News - From Partners

FPRX Stockcharts

View FPRX PE ratio, PS ratio stocks charts and compare with peers.
FPRX Chart
Note: Compare Five Prime Therapeutics stock price history with the index and industry peers.

Five Prime Therapeutics Valuation

PE ratio
(price earnings ratio)
4.89
PS ratio (
price to sales ratio
)
3.07
PB ratio (
price to book ratio
)
3.26

Five Prime Therapeutics Returns

ROE
(return on equity)
69%

Five Prime Therapeutics Financial Ratios

Asset Turnover
0.06
Receivables Turnover
103.2

FPRX Industry Peers

Company Price Change (%)
Halozyme Therapeutics (HALO)11.590.09 (0.78%)
Avexis (AVXS)51.20.34 (0.66%)
Bristol-myers Squibb (BMY)500.77 (1.56%)
Bluebird Bio (BLUE)65.350.05 (0.08%)
Pfizer (PFE)31.460.31 (0.98%)
Glaxosmithkline (GSK)38.920.2 (0.52%)
Eli Lilly (LLY)76.320.49 (0.64%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
MannKind (MNKD)0.690.05 (7.84%)
Trevena (TRVN)6.570.38 (6.14%)
Cara Therapeutics (CARA)11.950.52 (4.55%)
China Biologic Products (CBPO)111.213.89 (3.62%)
Arna Pharma (ARNA)1.40.03 (2.19%)
Enzo Biochem (ENZ)6.950.14 (2.06%)
Exelixis (EXEL)18.290.37 (2.06%)
Top gainers from Medical-Biomed-Genetics industry
* As of Jan 23, 2017
CompanyPriceChange (%)
Fate Therapeutics (FATE)2.740.32 (10.46%)
Kamada (KMDA)5.7740.33 (5.41%)
Nymox Pharmaceutical (NYMX)2.950.16 (5.14%)
Inovio Pharma (INO)5.980.3 (4.78%)
Intercept Pharma (ICPT)105.224.92 (4.47%)
VIVUS (VVUS)1.140.05 (4.2%)
Sangamo BioSciences (SGMO)3.50.15 (4.11%)
Top losers from Medical-Biomed-Genetics industry
* As of Jan 23, 2017

Five Prime Therapeutics Financial Statements

income statement20152014201320122011
Net Sales Or Revenues379.8M19.23M13.79M9.98M64.91M
Net Income249.64M-37.42M-28.87M-27.59M19.71M
Total Operating Expense92.82M56.8M43.2M37.77M45.24M
view Five Prime Therapeutics Inc income statement
balance sheet20152014201320122011
Total Assets548.28M155.63M81.79M44.09M58.57M
Total Liabilities115.07M70.42M23.76M23.68M19.22M
Shareholders Equity433.2M85.2M58.02M20.4M39.35M
view Five Prime Therapeutics Inc balance sheet
cash flow statement20152014201320122011
Net Increase (Decrease) In Assets Liabilities36.22M46.18M-0.23M5.42M-1.93M
Net Cash From (Used By) Operating Activities289.09M15.26M-25.33M-18.39M23.28M
Increase (Decrease) In Prop Plant And Equipment-2.42M-1.64M-0.8M-0.73M-0.97M
view Five Prime Therapeutics Inc cashflow statement

Five Prime Therapeutics Inc Stock News - Partner Headlines

Value Investing in BioPharma   on Nov 18, 2015

Five Prime Therapeutics Stock Message Board

Five Prime Therapeutics stock price ended the last trading day at 43.5. Five Prime Therapeutics market capitalization is 1.32B and it represents the total market value of FPRX stock. Five Prime Therapeutics valuation can be different from its intrinsic stock price when viewed from a value investors perspective.

The terms stocks and shares mean the same thing. For Ex: Five Prime Therapeutics stock price and Five Prime Therapeutics share price mean the same thing. The volume of shares traded stood at 459545 on the last trading day, as is evident from Five Prime Therapeutics stock chart, and FPRX stock quote data. Five Prime Therapeutics stock price history, gives the entire historical data for FPRX stock.